share_log

Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $2.5

Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $2.5

基准维持对Nutex Health的买入,将目标价下调至2.5美元
Benzinga ·  2023/05/17 05:18

Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $3 to $2.5.

基准分析师比尔·萨瑟兰维持Nutex Health(纳斯达克股票代码:NUTX)的买入,并将目标股价从3美元下调至2.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发